Entero Healthcare Solutions (ENTERO) Stock Overview
Engages in the distribution and marketing of pharmaceutical, surgical products and other allied services in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for ENTERO from our risk checks.
ENTERO Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Entero Healthcare Solutions Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,088.00 |
| 52 Week High | ₹1,390.00 |
| 52 Week Low | ₹944.00 |
| Beta | -0.62 |
| 1 Month Change | -19.67% |
| 3 Month Change | -12.10% |
| 1 Year Change | -4.42% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -5.35% |
Recent News & Updates
Entero Healthcare Solutions Limited Just Missed Earnings - But Analysts Have Updated Their Models
Shareholders might have noticed that Entero Healthcare Solutions Limited ( NSE:ENTERO ) filed its yearly result this...
ENTERO: Board Decisions And Option Grants Will Shape A Balanced Outlook
Analysts have revised their 12 month price target on Entero Healthcare Solutions from ₹1,497 to ₹1,410.50, citing updated assumptions around revenue growth, profit margins, discount rate, and future P/E. What's in the News A board meeting is scheduled for February 12, 2026 at 15:00 Indian Standard Time to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, along with a limited review (company filing).Recent updates
Entero Healthcare Solutions Limited Just Missed Earnings - But Analysts Have Updated Their Models
Shareholders might have noticed that Entero Healthcare Solutions Limited ( NSE:ENTERO ) filed its yearly result this...ENTERO: Board Decisions And Option Grants Will Shape A Balanced Outlook
Analysts have revised their 12 month price target on Entero Healthcare Solutions from ₹1,497 to ₹1,410.50, citing updated assumptions around revenue growth, profit margins, discount rate, and future P/E. What's in the News A board meeting is scheduled for February 12, 2026 at 15:00 Indian Standard Time to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, along with a limited review (company filing).Entero Healthcare Solutions Limited Just Missed EPS By 25%: Here's What Analysts Think Will Happen Next
Entero Healthcare Solutions Limited ( NSE:ENTERO ) came out with its third-quarter results last week, and we wanted to...Entero Healthcare Solutions (NSE:ENTERO) Has A Pretty Healthy Balance Sheet
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...India Urbanization And Market Consolidation Will Expand Pharma Distribution
Key Takeaways Rapid network scale and product expansion are driven by industry consolidation in a fragmented market and continued acquisition strategy. Operational efficiencies, margin gains, and cash flow improvement stem from proprietary tech, higher-margin segments, and a gradual shift to organic growth.Entero Healthcare Solutions Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
NSEI:ENTERO 1 Year Share Price vs Fair Value Explore Entero Healthcare Solutions's Fair Values from the Community and...Here's Why Entero Healthcare Solutions (NSE:ENTERO) Can Manage Its Debt Responsibly
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Entero Healthcare Solutions Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
There's been a notable change in appetite for Entero Healthcare Solutions Limited ( NSE:ENTERO ) shares in the week...The Return Trends At Entero Healthcare Solutions (NSE:ENTERO) Look Promising
There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'll want to see a...Entero Healthcare Solutions Limited (NSE:ENTERO) Looks Just Right With A 25% Price Jump
Entero Healthcare Solutions Limited ( NSE:ENTERO ) shares have had a really impressive month, gaining 25% after a shaky...With EPS Growth And More, Entero Healthcare Solutions (NSE:ENTERO) Makes An Interesting Case
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...What You Can Learn From Entero Healthcare Solutions Limited's (NSE:ENTERO) P/E
With a price-to-earnings (or "P/E") ratio of 56.7x Entero Healthcare Solutions Limited ( NSE:ENTERO ) may be sending...Analysts Have Been Trimming Their Entero Healthcare Solutions Limited (NSE:ENTERO) Price Target After Its Latest Report
It's been a sad week for Entero Healthcare Solutions Limited ( NSE:ENTERO ), who've watched their investment drop 14...Revenue Beat: Entero Healthcare Solutions Limited Beat Analyst Estimates By 9.0%
Last week, you might have seen that Entero Healthcare Solutions Limited ( NSE:ENTERO ) released its second-quarter...Shareholder Returns
| ENTERO | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | -2.6% | 2.2% | 0.6% |
| 1Y | -4.4% | 12.8% | -0.2% |
Return vs Industry: ENTERO underperformed the Indian Healthcare industry which returned 13.2% over the past year.
Return vs Market: ENTERO underperformed the Indian Market which returned 1.5% over the past year.
Price Volatility
| ENTERO volatility | |
|---|---|
| ENTERO Average Weekly Movement | 5.5% |
| Healthcare Industry Average Movement | 6.0% |
| Market Average Movement | 7.0% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.5% |
Stable Share Price: ENTERO has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: ENTERO's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | 4,111 | Prabhat Agrawal | www.enterohealthcare.com |
Entero Healthcare Solutions Limited engages in the distribution and marketing of pharmaceutical, surgical products and other allied services in India. The company involved in the distribution of generic formulations, active pharmaceutical ingredients, surgical consumables, rehabilitation products and devices, over the counter medical products, nutraceuticals, biosimilars, and biologics. It also provides nebulizers, personal protective, hygiene and surgical consumable products, homecare medical devices, gloves and mobility equipment, digital thermometers.
Entero Healthcare Solutions Limited Fundamentals Summary
| ENTERO fundamental statistics | |
|---|---|
| Market cap | ₹47.61b |
| Earnings (TTM) | ₹1.15b |
| Revenue (TTM) | ₹65.91b |
Is ENTERO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ENTERO income statement (TTM) | |
|---|---|
| Revenue | ₹65.91b |
| Cost of Revenue | ₹59.11b |
| Gross Profit | ₹6.80b |
| Other Expenses | ₹5.65b |
| Earnings | ₹1.15b |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 26.44 |
| Gross Margin | 10.32% |
| Net Profit Margin | 1.75% |
| Debt/Equity Ratio | 32.3% |
How did ENTERO perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/23 04:13 |
| End of Day Share Price | 2026/06/23 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2026/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Entero Healthcare Solutions Limited is covered by 4 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Nitin Agarwal | DAM Capital Advisors |
| Rahul Jeewani | IIFL Research |
| Anshuman Gupta | Investec Bank plc (UK) |